Approximately 1.6 million new cases of lung cancer are diagnosed each year throughout the
world. In many countries, the mortality related to lung cancer continues to rise. The outcomes …

The American Society of Clinical Oncology (ASCO) previously published evidencebased
guidelines for the treatment of unresectable non–small-cell lung cancer (NSCLC)[1]. ASCO …

El dolor es la causa más frecuente de consulta médica. La Asociación Internacional para el
Estudio del Dolor definió el dolor como" una experiencia sensitiva y emocional …

Purpose: The superiority of chemoradiotherapy (CRT) over radiation alone in locally
advanced non-small cell lung cancer (NSCLC) has been proven, but the relative merits of a …

Systemic therapy improves the survival and quality of life of patients with advanced stage
non-small cell lung cancer (NSCLC). Several new therapeutic options have emerged for …

Publications relating esophageal radiation toxicity to clinical variables and to quantitative
dose and dose–volume measures derived from three-dimensional conformal radiotherapy …

Purpose: To clarify whether the percentage of pulmonary volume irradiated to> 20 Gy (V20)
is related to the incidence and grade of radiation pneumonitis (RP) in cases of lung cancer …

PURPOSE: There are no published survival data after chemoradiotherapy (chemoRT) in
pathologically documented stage IIIB non–small-cell lung cancer. Studies of radiotherapy …

Purpose: To test the concept of taxane sequencing in combined-modality therapy, this phase
II trial (S9504) evaluated consolidation docetaxel after concurrent chemoradiotherapy in …

PURPOSE: To evaluate new drugs in combination with cisplatin in unresectable stage III
non–small-cell lung cancer, Cancer and Leukemia Group B (CALGB) conducted a …